Eli Lilly and Company
Contents
People
Board of Directors
Eli Lilly and Company list their Board of Directors for 2007 as[1]...
- Sidney Taurel - Chairman & CEO
- Winfried Bischoff
- J. Michael Cook
- Martin S Feldstein
- George M C Fisher
- J Erik Fyrwald
- Alfred G Gilman
- Karen N Horn
- John C Lechleiter
- Ellen R Marram
- Franklyn G Prendergast
- Kathi P Seifert
Executive Management
Eli Lilly and Company list their Executive Management for 2007 as comprising[2]...
- Sidney Taurel - Chairman and Chief Executive Officer
- Robert A Armitage - Senior Vice President and General Counsel
- Robert W Armstrong - Vice President, Global External Research and Development, Lilly Research Laboratories
- Alex M Azar II - Senior Vice President, Corporate Affairs and Communications
- Alan Breier - Vice President for Medical and Chief Medical Officer
- Bryce D Carmine - President, Global Product Development
- William W Chin - Vice President, Discovery Research and Clinical Investigation
- Robert A Cole - Vice President, Global Engineering and Environmental Health and Safety
- Deirdre P Connelly - President, Lilly USA
- Newton F Crenshaw - President and General Manager, Lilly Japan
- Andrew M Dahlem - Vice President, Lilly Research Labs Operations
- Frank M Deane - President, Manufacturing
- Alecia A DeCoudreaux - Vice President and General Counsel
- Johanna Carmel Egan - Vice President, Project Management
- Timothy R. Franson - Vice President, Global Regulatory Affairs
- Thomas W Grein - Vice President and Treasurer
- Simon N R Harford - Vice President and Controller
- Michael C Heim - Vice President, Information Technology and Chief Information Officer
- Abbas Hussain- Vice President Europe
- Patrick C James - President, Elanco Animal Health
- Peter J Johnson - Executive Director, Corporate Strategic Planning
- Elizabeth H Klimes - Vice President, Six Sigma
- John C Lechleiter - President and Chief Operating Officer
- Patricia Martin - Vice President, Global Diversity
- Anthony Murphy - Senior Vice President, Human Resources
- Anne Nobles - Vice President, Compliance and Enterprise Risk Management and Chief Compliance Officer
- Steven M Paul - Executive Vice President, Science and Technology, President of Lilly Research Laboratories
- Richard D Pilnik - Group Vice President and Chief Marketing Officer
- Derica W Rice - Senior Vice President and Chief Financial Officer
- Gino Santini - Senior Vice President, Corporate Strategy and Policy
- Sharon L Sullivan - Vice President, Human Resources–Global Compensation and HR Services
- Lorenzo Tallarigo - President, International Operations
- Jacques Tapiero - President, Intercontinental Operations
- Albertus van den Bergh - Vice President, Global Customer Solutions
- Thomas Verhoeven - Vice President for Process and Product Development
- Fionnuala Walsh - Vice President of Quality
- James A Ward - Vice President and Chief Procurement Officer
Patient Groups
Eli Lilly and Company UK report their relationships with Patient Groups in 2006 as follows[3]...
- British Lung Foundation - £20,000, all of which is dedicated to the UK Lung Cancer Coalition.
- Cancer Research UK Scotland - £1,500
- Cancerbackup - £23,000
- Continence Foundation - £11,800 (Lilly in partnership with Boehringer Ingelheim)
- Depression Alliance - $15,000 (Lilly in partnership with Boehringer Ingelheim)
- Diabetes UK - £31,836
- Diabetes UK Scotland - £500
- Hafal - £5,000
- MDF The BiPolar Organisation - £5,000
- Men’s Health Forum - £7,500
- Men’s Health Forum Scotland - £500
- Mesothelioma UK (National Macmillan Mesothelioma Resource Centre) - £20,000
- National Schizophrenia Fellowship (Scotland) - £5,000
- Rethink - £25,000
- Roy Castle Lung Cancer Foundation - £2,000
- Royal National Institute of the Blind Scotland - £4,000
- Sexual Dysfunction Association - £25,000
In 2006, the Lilly Grants Committee has made the following grants:
- Amersham and High Wycombe Branch of the Parkinson´s Disease Society - £400
- Birmingham Parents Group - £200
- British Lung Foundation Scotland - £900
- Centre for Mental Health - £15,000 (in partnership with Boehringer Ingelheim)
- Children´s Holiday Foundation Devon - £250
- Clydebank Asbestos Group - £17,560
- Diabetes Calshot Holiday - £100
- Diabetes West Midlands - £200
- Macmillan Cancer Relief - £2,000
- Mencap - £100
- National Osteoporosis Society (Winchester Support Group) - £100
- National Osteoporosis Society - £250
- Perth and Kinross ADHD Support Group - £1,412
- SeeAbility - £100
- TB Alert - £1,500
- The Tern Veterinary Group - £100
- Winchester Deanery Children´s Society - £150
Affiliations
- Alkermes Inc. - Research & Development alliance to develop inhaled formulations of insulin
- Nicholas Piramal India Limited - Research & Development alliance in the development of several pre-clinical drug candidates
- Structural GenomiX Inc. - Research & Development alliance.
- Amylin Pharmaceuticals Inc. - Commercialization alliance, development and commercialization of diabetes therapies.
- Quintiles Transnational Corp. - Commercialization alliance, promotion & marketing
- Boehringer Ingelheim - Commercialization alliance, promotion & marketing
References
- ↑ Elli Lilly and Company Director Profiles Accessed 27th December 2007
- ↑ Eli Lilly and Company Executive Management Accessed 27th December 2007
- ↑ Eli Lilly and Company Patient Group Relationships Accessed 31st December 2007
